Dark

Check out our Level2View

BNR
Burning Rock Biotech Limited
stock NASDAQ ADR

At Close

Jul 31, 2026

8.90USD+0.565%(+0.05)1,473

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-8.85)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 5, 2022

11:07AM EST Stocks That Hit 52-Week Lows On Wednesday Benzinga

Dec 28, 2021

09:20PM EST Burning Rock Biotech Limited (BNR) still expects its 2021 revenue to be at or slightly above RMB 500 million. RTTNews

08:05PM EST Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock) today announced that, based on the latest operating trends, the Company expects its 2021 revenue to be at or slightly above RMB500 million. GlobeNewswire Inc

Dec 27, 2021

10:00PM EST Burning Rock Announces Results of 2021 Annual General Meeting GlobeNewswire Inc

Nov 22, 2021

09:26AM EST Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Nov. 19, 2021: ROKU, BEAM, TDOC, MTLS, ACHR, MKFG, VLD, BNR Benzinga

Nov 18, 2021

02:05PM EST Following Rough Year, Is Burning Rock Set To Turn The Corner? Benzinga

07:55AM EST The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings Benzinga

Nov 17, 2021

08:53PM EST Burning Rock Biotech Limited (BNR) said that it has partnered with Merck KGaA, in companion diagnostics or CDx development for the MET inhibitor tepotinib in the mainland China market. RTTNews

08:15PM EST Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on GlobeNewswire Inc

Nov 16, 2021

08:38AM EST Recap: Burning Rock Biotech Q3 Earnings Benzinga

04:06AM EST Earnings Scheduled For November 16, 2021 Benzinga

Nov 4, 2021

03:08AM EDT Burning Rock Collaborates with IMPACT Therapeutics to Provide GlobeNewswire Inc

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 5, 2021

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Sep 30, 2021

07:43AM EDT The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug Benzinga

Sep 29, 2021

08:13AM EDT The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug Benzinga

Sep 1, 2021

07:32AM EDT The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering Benzinga

Aug 31, 2021

08:15AM EDT The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical Benzinga

12:31AM EDT Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended June 30, 2021. GlobeNewswire Inc

Aug 29, 2021

09:48AM EDT The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week Benzinga

Aug 3, 2021

07:55AM EDT The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business Benzinga

05:06AM EDT Burning Rock, and IMPACT Therapeutics Announced Global Strategic Partnership for Companion Diagnostics Development Benzinga

03:00AM EDT Burning Rock and IMPACT Therapeutics Announce a Global Strategic GlobeNewswire Inc

Aug 2, 2021

04:00AM EDT Burning Rock Schedules Second Quarter of 2021 Earnings Release on GlobeNewswire Inc

Jul 28, 2021

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

Jul 14, 2021

10:04AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021 Benzinga

05:45AM EDT CICC Initiates Coverage On Burning Rock Biotech with Outperform Rating, Announces Price Target of $39.94 Benzinga

Jun 23, 2021

03:01AM EDT Brenntag to acquire JM Swank and thus creates the leading Food Ingredients PR Newswire

May 25, 2021

07:53AM EDT The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal Benzinga

04:09AM EDT Earnings Scheduled For May 25, 2021 Benzinga

12:28AM EDT Burning Rock Biotech Q1 Net Loss RMB 171.4 Mln Or $26.2 Mln Vs Loss RMB 52.6 Mln Last Year RTTNews

12:19AM EDT Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended March 31, 2021. GlobeNewswire Inc

May 23, 2021

10:06AM EDT The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation Benzinga

May 19, 2021

05:06AM EDT Burning Rock Announces the Launch of Chinas GlobeNewswire Inc

May 12, 2021

04:00AM EDT Burning Rock to be Added to MSCI China Index GlobeNewswire Inc

Apr 29, 2021

07:36AM EDT Burning Rock Biotech And Abbisko Therapeutics To Develop CDx Assay For ABSK091 Benzinga

07:30AM EDT Burning Rock and Abbisko Therapeutics Announce Strategic GlobeNewswire Inc

Apr 13, 2021

08:16AM EDT The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug Benzinga

03:40AM EDT Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock) today announced that its liquid biopsy assay has achieved strong performance in the FDA-led Sequencing Quality Control Phase 2 (SEQC2) study, the results of which have been published on Nature Biotechnology. GlobeNewswire Inc

Mar 11, 2021

08:19AM EST The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena Benzinga

03:35AM EST Earnings Scheduled For March 11, 2021 Benzinga

Mar 10, 2021

07:00PM EST Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months and year ended December 31, 2020. GlobeNewswire Inc

Mar 6, 2021

10:58AM EST The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings Benzinga

Feb 23, 2021

07:25AM EST The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts Benzinga

Feb 8, 2021

08:00PM EST Burning Rock Announces Preliminary Fourth Quarter and Full Year GlobeNewswire Inc

Jan 20, 2021

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Dec 15, 2020

08:14AM EST Oncocyte, Burning Rock Execute Strategic Agreement To Distribute DetermaRX In China Benzinga

08:00AM EST Aligns Oncocyte with one of Chinas fastest growing NGS-based cancer therapy selection companies; China is considered to be the worlds largest early-stage lung cancer market GlobeNewswire Inc

07:52AM EST The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga

05:46AM EST Burning Rock Announced Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China Benzinga

01:37AM EST Burning Rock Biotech Enters Exclusive Licensing Agreement With Oncocyte To Bring DetermaRx To China RTTNews

01:33AM EST Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock) today announced that it entered into an exclusive licensing agreement with Oncocyte Corporation (NYSE American: OCX) to bring DetermaRx, a risk stratification test for early stage lung cancer patients, to China. GlobeNewswire Inc

Dec 8, 2020

10:55PM EST The lockup period of Burning Rock Biotech Ltd. (BNR) ends on December 9, 2020. RTTNews

Dec 4, 2020

06:35AM EST Burning Rock Biotech Prices Upsized Offering Of 2.24M ADS Offering At $25.75/ADS Benzinga

06:34AM EST Burning Rock Announces Pricing of Upsized Registered Secondary GlobeNewswire Inc

Dec 2, 2020

07:35AM EST The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod Benzinga

Dec 1, 2020

06:47PM EST Burning Rock Announces Proposed Registered Secondary Public GlobeNewswire Inc

04:46PM EST Burning Rock Shows Registration For 1.8M ADS From Selling Shareholders Benzinga

Nov 20, 2020

08:06AM EST The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger Benzinga

06:14AM EST Burning Rock Biotech Q3 Revenues RMB 123.9 Mln Or $18.2 Mln, Up 19.4% From RMB 103.7 Mln Last Year RTTNews

06:04AM EST Burning Rock Biotech Q3 EPS $(0.18) Misses $(0.12) Estimate, Sales $18.25M Beat $18.09M Estimate Benzinga

06:00AM EST Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months ended September 30, 2020. GlobeNewswire Inc

04:09AM EST Earnings Scheduled For November 20, 2020 Benzinga

Nov 16, 2020

05:49AM EST Burning Rock Announced In-Licensing of Myriad myChoice Tumor Testing in China Benzinga

Nov 15, 2020

08:00PM EST Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock) today announced that it entered into a development and commercialization agreement with Myriad Genetics, Inc. (NASDAQ: MYGN, Myriad) which will bring myChoice tumor testing for homologous recombination deficiency, or HRD, to China. GlobeNewswire Inc

Oct 20, 2020

09:30PM EDT Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock) today announced that new data for its early detection ELSA-seq test will be presented at the upcoming European Society for Medical Oncology (ESMO) Asia Virtual Congress, on Friday, November 20. GlobeNewswire Inc

09:30PM EDT Burning Rock Announces Preliminary Third Quarter 2020 Results and GlobeNewswire Inc

Sep 3, 2020

02:10AM EDT Burning Rock Biotech Limited (NASDAQ: BNR) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. GlobeNewswire Inc

Aug 13, 2020

08:18AM EDT The Daily Biotech Pulse: Mesoblast Awaits Adcom Test, BioCryst Rallies On Insider Buying, Sorrento Hits Back At Short Seller Benzinga

Aug 11, 2020

04:02AM EDT Earnings Scheduled For August 11, 2020 Benzinga

Aug 6, 2020

01:00AM EDT Brenntag reports solid results for the second quarter of 2020 PR Newswire

Jul 20, 2020

09:52PM EDT Burning Rock Biotech Limited (NASDAQ: BNR)today announced that it plans to release its unaudited financial results for the second quarter of 2020 before the U.S. market opens on August 11, 2020. Following the release, company management will host a conference call at 8:00 a.m. ET (8:00 p.m. Hong Kong time) the same day to discuss financial results. GlobeNewswire Inc

Jul 13, 2020

11:59AM EDT B of A Securities Initiates Coverage On Burning Rock Biotech with Buy Rating, Announces Price Target of $32.3 Benzinga

Share